The Colton Consortium for Autoimmunity today announced a new $15 million, three-year investment from the Colton Foundation to strengthen scientific leadership, expand faculty expertise, and advance collaborative research to accelerate breakthroughs in autoimmune disease across its partner institutions at New York University, Tel Aviv University, and Yale University.